Loading...
Mass spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: Comparison to IHC and FISH
BACKGROUND: Trastuzumab showed survival benefit for Her2-positive gastroesophageal cancers (GEC). Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) currently determine eligibility for trastuzumab-based therapy. However, these low-throughput assays often produce discordant or e...
Na minha lista:
Udgivet i: | Gastric Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2015
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4871781/ https://ncbi.nlm.nih.gov/pubmed/26581548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-015-0566-0 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|